Water-Filtered Infrared-A-Radiation (wIRA)
==========================================

Electromagnetic radiation with wavelengths between 760 nm (0.760 μm) and 1000'000 nm (1000 μm) is called infrared radiation (IR). This spectrum is divided into the three sub-ranges of IR-A (760 -- 1400 nm), IR-B (1400 -- 3000 nm), and IR-C (3000 -- 1000'000 nm and 3.0 -- 1000 μm) ([@B9]). The water-filtered IR-A-radiation (wIRA) shows a high degree of accordance with the terrestrial IR solar spectrum at noon as well as a strong reduction of emission within the water absorption bands at wavelengths of 840, 970, 1200, and 1470 nm with negligible contributions of IR at wavelengths longer than 1400 nm ([@B9]). The radiation of a halogen bulb is filtered through a water-filled cuvette in special irradiators ([@B9]; [@B55]). wIRA attains high tissue penetration with low thermal loads to the skin surface (in contrast to other sources of IR without the above-mentioned properties) and increases tissue temperature, oxygen partial pressure and tissue perfusion ([@B21]; [@B20]; [@B24]). The most important clinical effects of wIRA reported in patients include reduction of pain, inflammation, hypersecretion and improved wound healing ([@B19], [@B20]; [@B24]; [@B48]). wIRA in the clinical setting of wound healing has been extensively reviewed elsewhere ([@B20]; [@B24], [@B25]; [@B64]; [@B28]).

Application of wIRA in Patients
===============================

A variety of clinical applications for wIRA has been described (reviewed in [@B24], [@B26]), like improvement of wound healing in acute and chronic wounds ([@B20]; [@B64]; [@B25]; [@B10]; [@B28]), application in sports medicine and physiotherapy ([@B60]; [@B23]), treatment of Morbus Bechterew ([@B14]) or weight loss ([@B49]), in the neonatology field ([@B58]; [@B44]), for treatment of scleroderma lesions ([@B65], [@B63]), swallowing disorders and hypersalivation ([@B27]), therapy of recurrent breast cancer ([@B50]) and superficial tumors ([@B59]), or as a treatment method for actinic keratosis in combination with photodynamic therapy (PDT) ([@B62]; [@B18]). Moreover, wIRA can promote the penetration of topically applied substances ([@B51]) and is also attractive for cosmetics and wellness applications ([@B53]; [@B29]).

First introduced for chronic wound treatment in 1989, newer reports also recommend wIRA as a means to improve acute wound healing ([@B20]; [@B10]). After first anecdotal reports appeared describing single cases of better wound healing and reduced pain in patients following wIRA treatment, randomized control studies confirmed the beneficial effects of wIRA irradiation (reviewed in [@B20]; [@B64]; [@B25]; [@B28]).

Re-irradiation of local recurrent breast cancer is often challenging and, in severely pre-treated patients, also limited due to risks of skin damage ([@B50]). A combination of superficial hyperthermia and radiation therapy allows reduction of the total radiation dose while achieving local control ([@B50]). wIRA irradiation has been assessed as a potential contactless heating technique, which is especially promising in the treatment of large superficial, neoplastic skin areas, and ulcerated or bleeding lesions due to additional wound healing promoting effects ([@B50]; [@B59]). First applications of water-filtered infrared-A and visible light irradiation (wIRA/VIS) in combination with PDT resulted in reduced local pain compared to PDT with light emitting diodes (LED) ([@B62]) or with the light of a halogen bulb ([@B18]). In addition, wIRA treatment improved PDT efficacy by inducing increased blood flow and tissue oxygenation ([@B62]). wIRA can, moreover, be used in the treatment of other tumors such as malignant melanoma, vulvar carcinoma, skin metastases of different primary tumors, cutaneous T- and B-lymphomas, cutaneous large-area hemangiomatosis, inoperable squamous cell, basal cell and eccrine carcinoma ([@B59]).

Besides these myriad indications (reviewed by [@B24]), wIRA application has been shown to be beneficial for the clinical treatment of donor site infections in split-thickness skin grafts ([@B4]). [@B19] postulated the tendency of reduced wound infection rates upon postoperative wIRA treatment. Preoperative wIRA application in a study with 400 patients undergoing abdominal surgery significantly reduced surgical site infections ([@B42]). The combination of wIRA with PDT showed beneficial effects in the antimicrobial treatment of planktonic cultures and subgingival biofilms ([@B2], [@B3]; [@B40]). Furthermore, intracellular bacteria (*Chlamydia pecorum* and *Chlamydia trachomatis*) were significantly reduced *in vitro* by wIRA alone or in combination with visible light (wIRA/VIS) ([@B46], [@B45]; [@B54]; [@B43]).

wIRA-Induced Clinical Observations
==================================

The most important and reproducible clinical observations on wIRA treatment (increased tissue temperature, oxygen partial pressure, and tissue perfusion with decreased pain) are summarized in the first section of this report.

Wound centers are often relatively or absolutely hypothermic compared to the margins of the wound or unchanged skin areas ([@B24]; [@B48]), resulting in impaired wound healing; however, this can be treated by wIRA-induced elevation of local tissue temperature ([@B24]). Reduced local oxygen partial pressures, often present in chronic wounds, inhibit sufficient energy production for wound healing processes (e.g., respiratory burst of granulocytes) and predispose to wound infections ([@B24]). wIRA treatment can increase oxygen partial pressure, which has been demonstrated by implanted probe measurements ([@B19]). The accumulation of lactate (leading to acidosis) and inflammatory metabolites as a result of impaired blood circulation can induce pain. Patients reported less pain perception during and after wIRA treatment ([@B19], [@B20]). Improved microcirculation due to wIRA treatment leads to removal of pain metabolites and long-lasting increase in tissue temperature through improved blood flow ([@B24]).

Working Mechanism of wIRA
=========================

Physically, wIRA is a type of thermal radiation inducing thermal as well as non-thermal effects ([@B24]). Thermal effects are explained by the increased tissue temperature and the increased kinetic energy (energy absorption) of water molecules upon heat radiation, leading to temperature-dependent changes in the affected tissue ([@B8]; [@B59]). Non-thermal effects are independent of temperature changes and a result of direct stimulation of cells or cellular structures ([@B8]). However, as stated by [@B30], discriminating between thermal and non-thermal effects can be difficult when temperature changes are not strictly controlled. In cell culture, in contrast to skin models or even to a patient's skin, there is only one cell monolayer and the protective epidermis or temperature control by blood circulation is non-existent ([@B31], [@B30]).

On the cellular level, cytochrome c oxidase has been extensively discussed as a potential target of visible light and near-infrared treatment ([@B33], [@B35]; [@B37]). Cytochrome c oxidase is a large multicomponent membrane protein and the terminal enzyme of the respiratory chain in eukaryotic cells which mediates the transfer of electrons from cytochrome c to molecular oxygen ([@B33]). Multiple studies hypothesize that intermediate forms of cytochrome c (not fully oxidized, not fully reduced) are responsible for photo-acceptor properties ([@B33], [@B35]; [@B37]) and cytochrome c oxidase has recently been confirmed as a photo-acceptor ([@B52]). Nevertheless, four potential primary light action mechanisms are discussed, which are likely to occur as combinations: (1) alteration of redox properties and acceleration of electrons, (2) changed biochemical activity by local transient heating of chromophores (through conversion of excitation energy into heat energy), (3) production of reactive oxygen species (mainly O~2~^--^) and subsequent H~2~O~2~ production, and (4) photodynamic action and singlet oxygen production ([@B33]).

Biological responses of cells after irradiation might play a role as secondary mechanisms ([@B33]). The transduction of light action from mitochondria to the nucleus leading to DNA synthesis needs to be elucidated ([@B33]). A possible explanation is based on the fact that redox chains (including respiratory chain) are capable of controlling cellular homeostasis. Changes in the redox potential in mitochondria also affect the redox state in the cytoplasm and induce the signal transduction to the nucleus ([@B33]). Furthermore, the physiological significance of photosensitivity in enzymes of the respiratory chain is an important question to assess ([@B37]). [@B47] suggested that IR, for example during sunrise, is a natural process protecting cells from subsequent UV-radiation throughout the day, which is in accordance with conclusions by [@B5] and [@B8]. Multiple studies have confirmed that IR protects cells from UV cytotoxicity ([@B11]; [@B47]; [@B16], [@B15]). Wavelength-specific influence on cytochrome c oxidase has been reported by [@B36]; [@B38]; [@B39]; [@B37]) in multiple studies ([@B33], [@B34]; [@B52]). [@B22] demonstrated increased genomic instability, increased ROS formation, higher amounts of X-irradiated cells entering the S-phase, and impaired DNA double-strand break repair upon near-infrared-irradiation followed by clinically relevant X-ray doses. These synergistic effects are likely to affect the results of radiotherapy in cancer treatment ([@B22]), which is further confirmed by the above-mentioned combination of radiotherapy and heat-therapy with irradiation using wIRA/VIS irradiators ([@B50]; [@B59]).

Multiple authors have reported increased concentrations of reactive oxygen species (ROS) or decreased concentrations of antioxidative substances upon IR in human skin models *in vitro* or *in vivo* ([@B57], [@B56]; [@B13], [@B12]) and have suspected harmful effects of IR and wIRA on cell layers. Other authors investigated the secretion of matrix-metalloproteinases (MMP) (reviewed in [@B53]). An *in vivo* study investigating IR radiation on albino guinea pigs revealed harmful effects of IR similar to UV-damage ([@B41]). [@B53] give an overview of literature concerning the safety aspects of water-filtered infrared-A or other sources of IR, which the reader is referred to ([@B53]). Most of the studies performed are considered unsuitable as models for infrared or water-filtered IR on the human skin, since most of them lack important information about dose, exposure-time, spectrum, and application of irradiation. Corresponding controls need to be characterized and would help to distinguish the secondary effects of VIS or UV radiation from IR/wIRA effects ([@B53]). Other authors investigating ROS formation in fibroblasts were able to demonstrate increased ROS concentrations upon temperature increase in the samples alone, which leads to the conclusion of ROS activation being an unspecific thermal effect of the radiation ([@B31]). Therefore, the importance of suitable temperature control needs to be particularly emphasized and is vital in the interpretation of results for *in vitro* and *in vivo* studies ([@B53]; [@B29]).

Even though *in vitro* studies using high doses of wIRA or wIRA/VIS did not induce cell death ([@B54]), discomfort in patient due to heating of irradiated tissues might be possible. This can be prevented by either using lower doses \[e.g., 1500 -- 2000 W/m2 as in [@B50]\], by keeping a sufficient distance to the irradiator \[see [@B19] -- [Table 1](#T1){ref-type="table"}, [@B4]\] or by limiting the irradiation duration.

###### 

Summary of studies using wIRA as an antibacterialtreatment method.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Study design**        **Irradiation**                                  **Experimental setting**                                                                                                                                      **Specifications**                                                                                                                    **Results -- bacterial reduction**                                                                     **References**   
  ----------------------- ------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ---------------- --
  *In vitro/in situ^a^*   wIRA/VIS^1^, BTE31 filter:\                      Irradiation of planktonic cultures (*Streptococcus mutans*, *Enterococcus faecalis*)                                                                          aPDT^2^ using toluidine blue (TB^3^) concentrations of 5, 10, 25, and 50 μg/ml carried out in oral cavity of volunteers (*in situ*)   Up to 2 log~10~ reduction of *S. mutans* and *E. faecalis*                                             [@B2]            
                           - Spectrum: 570--1400 nm\                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                           - Dose: 200 mW/cm^2^\                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                           - Duration: 1 min                                                                                                                                                                                                                                                                                                                                                                                                                                                           

                                                                           Irradiation of salivary bacteria                                                                                                                                                                                                                                                                    Up to 3.7--5 log~10~ reduction of salivary bacteria                                                                     

                                                                           Irradiation of bacterially colonized bovine enamel slabs                                                                                                                                                                                                                                            Killing of oral bacterial colonization at all TB concentrations                                                         

  *In vitro/in situ^a^*   wIRA/VIS^1^, see [@B2]\                          Reduction of CFU^4^ in initial and mature biofilms                                                                                                            aPDT^2^ using TB^3^ or chlorine e6 (Ce6^5^) at a concentration of 100 μg/ml                                                           Initial biofilms: reduction of 3.8 log~10~ Mature biofilms: reduction of 5.7 log~10~                   [@B40]           
                           - Duration: 5 min                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  *In vitro/in situ^a^*   wIRA/VIS^1^, see [@B40]\                         Changes of microbial composition in initial and mature biofilms                                                                                               aPDT^2^ with TB^3^ and Ce6^5^                                                                                                         Reduction up to 3.76 log~10~                                                                           [@B1]            
                           - Distance: 20 cm                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  *In vitro/ex vivo^b^*   wIRA/VIS^1^, see [@B40]                          Irradation of eight different periodontal pathogens                                                                                                           aPDT with Ce6^5^ at a concentration of 100 μg/ml                                                                                      Reduction of 3.43 -- 8.34 log~10~                                                                      [@B3]            

                                                                           Irradation of subgingival biofilms                                                                                                                                                                                                                                                                  Reduction of 3.91 -- 4.28 log~10~                                                                                       

  Clinical trial          wIRA (590--1400 nm) or VIS (590 - 780 nm):\      Post-surgery irradiation with wIRA or VIS (control) Assessment of wound healing, pain, oxygen partial pressure, and temperature                               Double-blinded study                                                                                                                  Trend toward a lower rate of wound infections in wIRA group                                            [@B19]           
                           - Duration: 20 min\                                                                                                                                                                                                                                                                                                                                                                                                                                                         
                           - 2 times/day from day 2 -- 10 post-surgery\                                                                                                                                                                                                                                                                                                                                                                                                                                
                           - Distance: 25 cm                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Clinical trial          wIRA (590 -- 1400 nm) or VIS (590 -- 780 nm):\   Pre-operative care plus wIRA or VIS (control) irradiation for 20 min, followed by laparotomy Assessment of wound healing, pain and surgical site infections   Double-blinded study Assessment of surgical site infections (SSI) at day 30 post-surgery                                              Relative risk for SSI in wIRA-treated patients: 0.42 (*p* = 0.018), wIRA acts protective against SSI   [@B42]           
                           - 20 min pre-operative\                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                           - Dose: 200 -- 225 mW/cm^2^\                                                                                                                                                                                                                                                                                                                                                                                                                                                
                           - Distance: 27 cm                                                                                                                                                                                                                                                                                                                                                                                                                                                           

  Case report             wIRA (Spectrum: N/A^6^)\                         Patient with donor site infection after split thickness skin graft -- wound cultures: *S. aureus, E. coli, S. epidermidis* (MRSE^7^)                          Surgical debridement, removing of hypertrophic granulation tissue, daily wound dressing, and irradiation                              Improvement of wound healing: completed or nearly completed wound closure                              [@B4]            
                           - 30 min\                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                           - 3 times/day\                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                           - Distance: 60 cm                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1

wIRA/VIS, water-filtered infrared-A and visible light irradiation.

2

aPDT, antimicrobial photodynamic therapy.

3

TB, toluidine blue.

4

CFU, colony forming units.

5

Ce6, chlorine e6.

6

N/A, not available (no data in publication).

7

MRSE, methicillin-resistent

Staphylococcus epidermidis.

a

For detailed material and method section, see

Al-Ahmad et al., 2013

,

2015

and

Karygianni et al., 2014

briefly:

in vitro

examination of bacterial colonies combined with: - Bovine enamel slabs (BES), fixed on jaw splints, transferred into oral cavity of volunteers for 2 h

in situ

(

Al-Ahmad et al., 2013

). - BES, fixed on upper jaw splints, transferred into oral cavity of volunteers for 2 h or 3 days

in situ

(

Karygianni et al., 2014

). - BES, see above

in situ

(

Al-Ahmad et al., 2015

).

b

For detailed material and method section, see

Al-Ahmad et al., 2016

briefly:

in vitro

examination of periodontal pathogens and

ex vivo

subgingival biofilm samples from 6 patients with periodontitis.

wIRA as an Antibacterial Treatment Method
=========================================

A summary of studies using wIRA as an antibacterial treatment method is presented in [Table 1](#T1){ref-type="table"}. [@B2] were the first authors to investigate the efficacy of visible light in combination with water-filtered infrared-A (VIS and wIRA) in the killing of bacteria. In their study, antimicrobial photodynamic therapy (aPDT) was tested using toluidine blue (TB) at different concentrations as a photosensitizer and visible light and water-filtered infrared-A radiation as light sources. Bacterial samples tested were planktonic cultures of *Streptococcus mutans* and *Enterococcus faecalis*, bacteria occurring in human saliva or originating from bovine enamel slabs. These investigations were carried out in the oral cavity of healthy volunteers to investigate the effects of aPDT on bacterial colonization *in situ*. All the aforementioned bacteria were severely diminished in load after aPDT treatment, with a maximal reduction of 3.7--5 log~10~ in salivary bacteria ([@B2]). A further study also investigated the action of aPDT consisting of chlorine e6 and wIRA/VIS on multiple periodontal pathogens (*Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Eikenella corrodens, Actinomyces odontolyticus, Fusobacterium nucleatum, Parvimonas micra, Slackia exigua*, and *Atopobium rimae*) and subgingival biofilms *in situ*, which are protected against antibiotic treatment or disinfection by various mechanisms ([@B3]). [@B40] investigated the effect of aPDT (using toluidine blue or chlorine e6) with wIRA/VIS on initial and mature oral biofilms and observed bacterial reductions of 3.8 and 5.7 log~10~, respectively. *In situ* oral biofilms were severely reduced and the proportion of surviving bacteria was altered compared to controls upon wIRA/VIS radiation, which further encourages the clinical use of wIRA/VIS as treatment for periimplantitis, and periodontitis ([@B1]). Common light sources in aPDT include light-emitting diodes (LED) and wide-band halogen lamps ([@B3]). wIRA/VIS was proven to be beneficial for aPDT therapy in multiple studies ([@B2], [@B3]; [@B40]), also including the advantages of using a broader wavelength-spectrum than LED, reduced risk of tissue overheating compared to halogen lamps, and its well-known beneficial effects on wound healing ([@B3]).

In addition to the above-mentioned beneficial aspects of wIRA/VIS in aPDT, the application of wIRA/VIS alone (without photosensitizer) had beneficial effects on wound infections after abdominal surgery ([@B19]; [@B42]). The case report of a patient with a donor site infection in a split-thickness skin graft is especially worth mentioning, since *Staphylococcus aureus, Escherichia coli*, and *Staphylococcus epidermidis* (Methicillin-resistant, MRSE) were isolated from the wound site and the combination of surgical intervention, daily wound dressing, and combined wIRA/VIS treatment led to almost complete healing of the infected sites within 5 weeks ([@B4]).

Finally, not only extracellular bacteria, wound infections and biofilm formation can be treated with wIRA/VIS, but this irradiation technique has also been demonstrated to reduce acute chlamydial infections *in vitro* ([@B46], [@B45]; [@B54]; [@B43]). The reducing effects of wIRA/VIS on chlamydial infectivity were confirmed in multiple *in vitro* studies, using animal (Vero cells and *C. pecorum*) and human cell culture models (a genital model with HeLa cells and *C. trachomatis* Serovar E or an ocular model with human conjunctival epithelial cells and *C. trachomatis* Serovar B), different chlamydial infectious doses, different irradiation time points, irradiation doses or wavelengths (wIRA alone (black filter, 780--1400 nm), wIRA/VIS (orange filter, 595--1400 nm or no filter, 380--1400 nm), and temperature controlled settings ([@B46], [@B45]; [@B54]; [@B43]). Results of previous studies investigating wIRA or wIRA/VIS for the treatment of chlamydial infections are summarized in [Table 2](#T2){ref-type="table"}.

###### 

Summary of studies investigating the effects of wIRA or wIRA/VIS in different cell-*Chlamydia* systems.

                                 **Cell + *Chlamydia* model^3^**                           **Time-point of irradiation^4^**                          **Duration + dose \[W/m^2^\]^5^**      **Results^6^**                        **References**
  ------------- ---------------- --------------------------------------------------------- --------------------------------------------------------- -------------------------------------- ------------------------------------- ------------------------
  wIRA^1^       Single dose      HCjE (prim), HeLa (perm), Vero (perm), CtB, CtE, and Cp   before infection, 0 hpi, and 40 hpi                       20/30 min, 650 or 2000                 IFA: Inclusion rate ↓                 [@B45]; [@B54]
                                                                                                                                                                                            Titer: infectivity ↓ (2000),          
                                                                                                                                                                                            infectivity ↓ (650: only Cp + Vero)   
                                                                                           →EB irradiation: infectivity reduction dependent on VIS                                                                                
                Quadruple dose   HCjE (prim) + CtB                                         Before infection (8, 5, 3, and 0 h)                       30 min, 2000                           Titer: infectivity ↓                  [@B54]
  wIRA/VIS^2^   Single dose      HCjE (prim), HeLa (perm), Vero (perm), CtB, CtE, and Cp   Before infection, 0 hpi, 40 hpi                           20/30 min, 1000, 2000, 2100, or 3700   IFA: inclusion rate ↓                 [@B46]; [@B45]; [@B54]
                                                                                                                                                                                            Titer: infectivity ↓                  
                                                                                                                                                                                            TEM: number of chlamydial             
                                                                                                                                                                                            particles in inclusion ↓              
                                                                                                                                                                                            TcS: Non-thermal effects involved     
                Triple dose      HeLa + CtE                                                24, 36, and 40 hpi                                        20 min, 3700                           IFA: inclusion rate ↓                 [@B46]
                                                                                                                                                                                            Titer: infectivity ↓                  
                                                                                                                                                                                            TEM: number of chlamydial             
                                                                                                                                                                                            particles in inclusion ↓, EBs ↓,      
                                                                                                                                                                                            RBs ↑                                 
                                                                                                                                                                                            Array: cytokine/chemokine ↑           
                Triple dose      HeLa + CtE                                                24, 36, and 40 hpi                                        30 min, 2340 -- 3400                   IFA: inclusion size ↓                 [@B43]
                                                                                                                                                                                            Titer: infectivity ↓                  
                                                                                                                                                                                            ELISA: IL-6 ↑, IL-8 ↑, RANTES ↑       
                Quadruple dose   HCjE (prim) + CtB                                         Before infection (8, 5, 3, and 0 h)                       30 min, 2100                           Titer : infectivity ↓                 [@B54]

1

wIRA, water-filtered infrared-A (wavelengths 780--1400 nm).

2

wIRA/VIS, water-filtered infrared-A and visible light \[380 -- 1400 nm or 595 -- 1400 nm (

Rahn et al., 2016

)\].

3

Prim, primary cell line; Perm, permanent cell line; HCjE, human conjunctival epithelial cells; HeLa, human cervical carcinoma cells; Vero, African green monkey kidney cells; CtB,

Chlamydia trachomatis

serovar B (ocular strain); CtE,

Chlamydia trachomatis

serovar E (genital strain); Cp,

Chlamydia pecorum.

4

Before infection, only irradiation of cells. 0 hpi, hours post infection (hpi). Irradiation of elementary bodies (EBs) directly before infection. 40 hpi, 40 h post infection.

5

Duration, duration of irradiation exposure; W/m

2

, irradiation intensity/dose (in Watts per square meter).

6

IFA, immunofluorescence assay -- determination of inclusion frequency, morphology, or size. Titer, titration by subpassage to analyze chlamydial infectivity (IFU/ml, inclusion forming units per ml); TEM, transmission electron microscopy -- information about ultrastructure of chlamydial inclusions; TcS, temperature-controlled setting (water bath set to 34°C vs. 37°C).

Since chlamydiae are obligate intracellular bacteria, the first investigations of wIRA treatment for chlamydial infections focused on possible deteriorating effects of wIRA irradiation on host cells. Detrimental effects on host cells were not present in HeLa (human cervical carcinoma cells) and Vero (African green monkey kidney) cells ([@B46]). In primary human conjunctival epithelial cells (HCjE), wIRA treatment reduced cell metabolism as measured by Alamarblue assay, whereas wIRA/VIS did not. However, the additional counting of cell numbers per high power field (400× magnification) did not show decreased cell numbers after either wIRA/VIS or wIRA irradiation treatment ([@B54]). Following these findings, further investigations included *ex vivo* models, which are important for potential future application of wIRA as a trachoma treatment method ([Figure 1](#F1){ref-type="fig"}). Although a temperature increase was demonstrated in constantly perfused pig eyes upon high irradiation doses, no wIRA/VIS-dependent phosphorylation of stress kinases was observed in retinal explants from adult or postnatal (10-day-old) mice ([@B54]).

![Water-filtered infrared-A and visible light irradiation (wIRA/VIS) as a potential future treatment device to combat blinding trachoma. Blinding trachoma is a neglected tropical disease present in Sub-Saharan Africa, in particular affecting children. It is caused by recurrent infections of the conjunctival epithelium by *C. trachomatis* leading to fibrosis and scarring of the conjunctiva, ocular discharge, trichiasis, and corneal opacity with blindness (left aspect of the figure). *C. trachomatis* is an obligate intracellular bacterium with a complex life cycle including the attachment of an elementary body (EB) to an epithelial cell, forming an intracytoplasmic inclusion with differentiation into reticulate bodies and multiplication by binary fission and finally lysis of the inclusion with the release of EBs (bottom aspect of the figure). wIRA/VIS irradiation produced by radiation of a halogen bulb, filtered through a water-filled cuvette in special irradiators (right aspect of the figure) could reduce chlamydial burden *in vitro* by affecting mature inclusions and as well as by reducing infectious EB load. Future *in vivo* wIRA/VIS treatment of trachoma patients would be applied by irradiation of the *C. trachomatis*-infected conjunctiva (in green) through a closed eyelid reaching the infected part (inner conjunctival lining) without harming the inner structures of the eye such as the cornea, the vitreous body or the retina (central aspect of the figure).](fmicb-10-01053-g001){#F1}

Irradiation of HCjE cells alone prior to chlamydial infection reduced subsequent chlamydial infectivity, indicating a cell-associated, protective effect of wIRA/VIS against chlamydial infections ([@B54]). Irradiating elementary bodies (EBs -- infective particles in the chlamydial life cycle) prior to infection of host cells also reduced chlamydial infectivity ([@B46], [@B45]; [@B54]) and the combination of both prior to infection further increased this effect ([@B54]).

The irradiation of mature chlamydial inclusions *in vitro* with either wIRA or wIRA/VIS at doses of 2000 or 3700 W/m^2^ led to a decrease of the number of infective particles in the chlamydial inclusions without causing changes in the distribution of chlamydial maturation stages ([@B46], [@B45]). Triple dose irradiation of growing *Chlamydia*, on the other hand, led to increased proportions of reticulate bodies (RBs -- the reproducing form of *Chlamydi*a) and decreased EB formation, whereas no increased formation of aberrant bodies \[AB -- a sign of the chlamydial stress response ([@B7])\] could be observed ([@B46]). The distribution differences in chlamydial development stages indicate a yet unknown effect of wIRA/VIS on the chlamydial development cycle ([@B46]).

Future Research Directions
==========================

To elucidate the mechanism of wIRA/VIS in antibacterial effects or in wound healing, transcriptomics or metabolomics would provide useful information regarding gene expression and protein translation upon irradiation. Since cytochrome c oxidase has been claimed to be the primary photo-acceptor molecule, investigating the molecule itself, and the broader mitochondrial metabolism might provide useful information regarding biological effects following wIRA irradiation.

Various bacterial species have been demonstrated to display thermo-sensitivity, therefore local thermal therapies (as e.g., wIRA therapy) are important fields for future investigations ([@B17]). Heat treatment has further been proven beneficial for *Leishmania*-induced skin lesions ([@B6]) and buruli ulcer, another tropical disease, which is caused by *Mycobacterium ulcerans* ([@B32]; [@B61]). These neglected tropical diseases might represent further possible indications for the use of wIRA.

In view of current worldwide antibiotic resistance problems, studies investigating wound infection treatment with heat and light have become more important in the last few decades, with promising results for these treatments. Further investigations are needed to gain deeper insight into the working mechanisms of such methods, their safety aspects, and applicability in patients.
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